It's important to note that even with significant weight regain, many patients do not return entirely to their pre-treatment weight, particularly if they maintain some of the healthy habits developed during treatment
No untoward side effects that we didnt anticipate. According to Carroll, Hims has not had to report any adverse effects to the FDA
Shipping took an extra day but the quality is there
This isnt unusual for a just-launched telehealth company, but it means patients have zero independent data to evaluate the actual patient experience
Appetite control and weight loss with GLP-1 receptor agonists: Semaglutide and Liraglutide
Clinical trials have shown Semaglutide GLP-1 to help patients lose an average of 15% of their body weight, and liraglutide has demonstrated significant reductions in body weight, body mass index (BMI), and waist circumference